tiprankstipranks
Trending News
More News >
pc:axolb

Axol Bioscience

Axol Bioscience develops and supplies high-quality induced pluripotent stem cell (iPSC)-derived cells, reagents, and specialist services to pharmaceutical, biotechnology, contract research organizations, and academic institutions worldwide. The company focuses on providing physiologically relevant iPSC-derived disease models and scalable cell manufacturing to support drug discovery and disease research across neuroscience, ophthalmology, and cardiovascular domains.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$3M
Total Amount Raised$3M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$3M
Latest Funding Amount$3M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 13, 2026
Investment
$2.80M

Investors

Investor Name
Funding Round

Related News and Analysis